1. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network PEGylated Drugs Market Size, Industry Analysis Report, Regional Outlook Application Development Potential & Forecast, 2017 – 2024: Global Market Insights Inc.

2. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Pegylated Drugs Market can be used to treat chronic disorders like cancer. Cancer is of the leading cause of death and its prevalence is rising continuously.  Binding of PEG with drugs facilitates its entry into the tumor cell and to give better therapeutic results.  demand for these drugs is high as it offers different advantages such as reduced degradation by metabolic enzymes, elimination of immunogenicity and increased residence in blood.  also enhances the solubility of drugs and reduces effects of proteolytic enzymes, thus improves the bioavailability.  PEGylation refers to change in structure of protein by linking one or more polyethylene glycol (PEG) chains. Brief Detail of Pancreatic PEGylated Drugs Market :

3. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  It is easily soluble in organic and aqueous solutions and is non-toxic in nature. The chain binds to the drugs covalently and make it sterically stable.  The polymer thus formed is non-toxic, non-antigenic, non-immunogenic, and highly water soluble. It further increases half-life of the drug and reduces dose frequency by preventing renal excretion of drugs.  Increasing protein stability and circulating half-life, and increased R&D spending are some other impact rendering factors for industry.  However, adverse drug reactions associated can impede market growth during forecast period.

4. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  As per center for disease control and prevention, in U.S. around 400 babies suffer from hemophilia each year.  Demand for long acting drugs with extended half-life to treat such diseases is increasing in the region.  The increased adoption of protein based drugs is expected to drive the U.S. market over forecast period.  Asia pacific is predicted to show significant growth due to rising prevalence of chronic diseases like cancer and arthritis.  For instance, in China cancer caused 2.8 million deaths and 4.3 million new cases were diagnosed. The high prevalence of such diseases will boost the regional revenue share over the forecast timeframe. Regional Analysis of Pancreatic PEGylated Drugs Market

5. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On PEGylated Drugs Market @ http://bit.ly/2vsOZPThttp://bit.ly/2vsOZPT Request for an in-depth table of contents for this report @ http://bit.ly/2ubLQPk http://bit.ly/2ubLQPk

6. © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: